/
/
Michael J Fox Foundation

Michael J Fox Foundation

Objective: The Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.

Award Amount: Funding amount varies case by case
Due Date: Rolling Deadline

Objective: This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.

Award Amount: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs.
Due Date: Rolling Deadline.

Objective: The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson’s disease and other movement disorders — by training movement disorder clinician-researchers who can provide expert care and lead scientific advances.

Award Amount: $180,000 total to be used during the two-year fellowship
Due Date: December 4, 2025

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

wpc2026_logo

IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...

IMG_1591

For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....

ChatGPT Image 27 mag 2026, 10_24_30

📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...

Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...

Article wordpress

A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...

ChatGPT Image 25 gen 2026, 03_00_53

We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...